Cargando…

Sociodemographic and Clinical Characteristics of Transgender Adults in Australia

Background: Over the last 10 years, increases in demand for transgender health care has occurred worldwide. There are few data on clinical characteristics of Australian adult transgender individuals. Understanding gender identity patterns, sociodemographic characteristics, gender-affirming treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheung, Ada S., Ooi, Olivia, Leemaqz, Shalem, Cundill, Pauline, Silberstein, Nicholas, Bretherton, Ingrid, Thrower, Emily, Locke, Peter, Grossmann, Mathis, Zajac, Jeffrey D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308273/ https://www.ncbi.nlm.nih.gov/pubmed/30596151 http://dx.doi.org/10.1089/trgh.2018.0019

Ejemplares similares

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

Insulin resistance in transgender individuals correlates with android fat mass
por: Bretherton, Ingrid, et al.
Publicado: (2021)

The Health and Well-Being of Transgender Australians: A National Community Survey
por: Bretherton, Ingrid, et al.
Publicado: (2021)

Bone Microarchitecture in Transgender Adults: A Cross‐Sectional Study
por: Bretherton, Ingrid, et al.
Publicado: (2022)

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study
por: Foster Skewis, Lucas, et al.
Publicado: (2021)

Factors associated with suicide attempts among Australian transgender adults
por: Zwickl, Sav, et al.
Publicado: (2021)

Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study
por: Nolan, Brendan J, et al.
Publicado: (2022)

Correction to: Factors associated with suicide attempts among Australian transgender adults
por: Zwickl, Sav, et al.
Publicado: (2021)

LBODP089 Effects Of Low-dose Oral Micronised Progesterone On Sleep, Psychological Distress And Breast Development In Transgender Individuals Undergoing Feminising Hormone Therapy: A Prospective Controlled Study
por: Nolan, Brendan J, et al.
Publicado: (2022)

Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy
por: Nolan, Brendan J., et al.
Publicado: (2020)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review
por: Spanos, Cassandra, et al.
Publicado: (2020)

SUN-039 Estradiol Dose and Concentrations in Transfeminine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

Pelvic Pain in Transgender People Using Testosterone Therapy
por: Zwickl, Sav, et al.
Publicado: (2023)

Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia
por: Balcerek, Matthew I., et al.
Publicado: (2021)

Health Needs of Trans and Gender Diverse Adults in Australia: A Qualitative Analysis of a National Community Survey
por: Zwickl, Sav, et al.
Publicado: (2019)

Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults Seeking Masculinization: A Randomized Clinical Trial
por: Nolan, Brendan J., et al.
Publicado: (2023)

Testosterone concentrations and prescription patterns of 1% testosterone gel in transgender and gender diverse individuals
por: Nolan, Brendan J., et al.
Publicado: (2022)

Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals
por: Cheung, Ada S, et al.
Publicado: (2020)

The impact of the first three months of the COVID-19 pandemic on the Australian trans community
por: Zwickl, Sav, et al.
Publicado: (2021)

Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trial
por: Cheung, Ada S., et al.
Publicado: (2021)

OR31-04 Testosterone Therapy On Gender Dysphoria, Depression, And Suicidality In Transgender And Gender Diverse Individuals Seeking Masculinisation: A Randomised Controlled Trial
por: Nolan, Brendan J, et al.
Publicado: (2023)

Gender-affirming hormone therapy induces specific DNA methylation changes in blood
por: Shepherd, Rebecca, et al.
Publicado: (2022)

Androgen deprivation causes selective deficits in the biomechanical leg muscle function of men during walking: a prospective case–control study
por: Cheung, Ada S., et al.
Publicado: (2016)

Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial
por: Warren, Annabelle M., et al.
Publicado: (2022)

Modelling the Impact of Reducing Ultra-Processed Foods Based on the NOVA Classification in Australian Women of Reproductive Age
por: Habibi, Nahal, et al.
Publicado: (2022)

Hypothalamic-Pituitary-Thyroid Axis Set Point Alterations Are Associated With Body Composition in Androgen-Deprived Men
por: Hoermann, Rudolf, et al.
Publicado: (2017)

The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments
por: Venkatesh, Varun S., et al.
Publicado: (2022)

Estradiol Therapy in the Perioperative Period: Implications for Transgender People Undergoing Feminizing Hormone Therapy
por: Nolan, Brendan J., et al.
Publicado: (2020)

Young-Onset Gastrointestinal Adenocarcinoma Incidence and Survival Trends in the Northern Territory, Australia, with Emphasis on Indigenous Peoples
por: Shepherdson, Mia, et al.
Publicado: (2022)

Clinical features and prevalence of Klinefelter syndrome in transgender individuals: A systematic review
por: Liang, Bonnie, et al.
Publicado: (2022)

Sociodemographic Variation in Consumption Patterns of Sustainable and Nutritious Seafood in Australia
por: Farmery, Anna K., et al.
Publicado: (2018)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

Association of Media Coverage of Transgender and Gender Diverse Issues With Rates of Referral of Transgender Children and Adolescents to Specialist Gender Clinics in the UK and Australia
por: Pang, Ken C., et al.
Publicado: (2020)

Anxiety and Depression in Early Gestation and the Association with Subsequent Gestational Diabetes Mellitus in a Disadvantaged Population
por: Pathirana, Maleesa M., et al.
Publicado: (2023)

Prevalence of Metabolic Syndrome in Women After Maternal Complications of Pregnancy: An Observational Cohort Analysis
por: Aldridge, Emily, et al.
Publicado: (2022)

Effectiveness of a nurse practitioner-led cardiovascular prevention clinic at reduction of metabolic syndrome following maternal complications of pregnancy: a preliminary analysis
por: Aldridge, Emily, et al.
Publicado: (2022)

Sociodemographic Drivers of Donor and Recipient Gender Disparities in Living Kidney Donation in Australia
por: Kim, Siah, et al.
Publicado: (2023)

Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
por: Silva, Eliane D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ho5p1d7gqhacp52aahnuiojju9